Heart and Vascular
HTX-001
A Two-Part, Phase 1, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and WISPER Target Engagement of HTX-001 in Adult Healthy Participants (Part 1) and in Adult Participants with Nonobstructive Hypertrophic Cardiomyopathy (Part 2)
Contact Research Team:
[email protected]
Site principal investigator:
Erika Hutt Centeno, MD
Learn more about this study:
NCT07867288